Comparison of the immunogenicity of Dukoral® oral cholera vaccine between renal transplant recipients on either a calcineurin inhibitor or mycophenolate – A controlled trial

Autor: Darius Soonawala, Marjolein A.C. Uijlings, Leonardus G Visser, Emile F.F. Jonker

Publikováno v: Vaccine, 37(23), 3133-3139

Background The evidence for recommendations regarding vaccination in solid organ transplant recipients is sparse. There is little data comparing vaccine responses between groups on different immunosuppressive drugs. This study was conducted to evalua

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0ed6a42c136c66dfdcd870552907fbf
https://doi.org/10.1016/j.vaccine.2019.04.010

Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation – A systematic review of randomized trials, observational studies and case reports

Autor: Leo G. Visser, Emile F.F. Jonker, Christoph Hatz, Silja Bühler, Veronika K. Jaeger, Evelina Croce

Publikováno v: Vaccine, 35(9), 1216-1226

Background Live vaccines are generally contraindicated on immunosuppressive therapy due to safety concerns. However, data are limited to corroborate this practice. Objectives To estimate the safety of live vaccinations in patients with immune-mediate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15d4ea503e454023333a64e9cc470d13
https://doi.org/10.1016/j.vaccine.2017.01.048

Single visit rabies pre-exposure priming induces a robust anamnestic antibody response after simulated post-exposure vaccination: results of a dose-finding study

Autor: Emile F.F. Jonker, Leonardus G Visser

Publikováno v: Journal of Travel Medicine, 24(5)

Background The current standard 3-dose intramuscular rabies PrEP schedule suffers from a number of disadvantages that severely limit accessibility and availability. The cost of is often prohibitive, it requires 3 visits to the clinic, and there are r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eef1518942360e3dc42a1427c1a9341
https://hdl.handle.net/1887/115090

A Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination

Autor: Perry J.J. van Genderen, Abraham Goorhuis, Godelieve J. de Bree, Emile F.F. Jonker, Ester B. M. Remmerswaal, Martin P. Grobusch, Ineke J. M. ten Berge, Ester M. M. van Leeuwen, Leo G. Visser, Adriëtte W. de Visser, Rosanne W. Wieten

Publikováno v: PLoS ONE
PLoS ONE, 11(3). Public Library of Science
PLoS ONE, 11(3). PUBLIC LIBRARY SCIENCE
PLoS ONE, Vol 11, Iss 3, p e0149871 (2016)

Introduction Prompted by recent amendments of Yellow Fever (YF) vaccination guidelines from boost to single vaccination strategy and the paucity of clinical data to support this adjustment, we used the profile of the YF-specific CD8+ T-cell subset pr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53e9e0dd606839c004ddb523cb8d8937
https://hdl.handle.net/1887/99323

Advances and controversies in yellow fever vaccination

Autor: Anna H. Roukens, Leonardus G Visser, Emile F.F. Jonker

Ever since its development in 1937, the live-attenuated 17D yellow fever (YF) vaccine has been one of the most effective vaccines available to man. In this review we highlight the major steps in the development of 17D YF vaccine. We discuss the use o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16e46349ecbac9929bc1fe0d1ea91e73
https://europepmc.org/articles/PMC3991151/